Passage Bio Ownership | Who Owns Passage Bio?
Passage Bio Ownership Summary
Passage Bio is owned by 55.31% institutional investors, 0.21% insiders, and 44.48% retail investors. Lynx1 capital management lp is the largest institutional shareholder, holding 14.99% of PASG shares. Worldwide Healthcare Ord is the top mutual fund, with 3.28% of its assets in Passage Bio shares.
PASG Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Passage Bio | 55.31% | 0.21% | 44.48% |
| Sector | Healthcare Stocks | 492.67% | 11.09% | -403.76% |
| Industry | Biotech Stocks | 295.31% | 11.22% | -206.53% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Lynx1 capital management lp | 9.26M | 14.99% | $5.25M |
| Vestal point capital, lp | 6.10M | 9.62% | $2.44M |
| Orbimed advisors | 6.06M | 9.55% | $2.42M |
| New leaf venture partners | 2.50M | 3.94% | $19.98M |
| Tang capital management | 1.50M | 2.37% | $600.45K |
| Renaissance | 1.38M | 2.24% | $783.43K |
| Acadian asset management | 933.76K | 1.47% | $372.00K |
| Blackrock | 817.53K | 1.45% | $649.28K |
| Blackrock funding, inc. /de | 594.87K | 0.94% | $238.13K |
| Bridgeway capital management | 556.14K | 0.90% | $315.39K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| New leaf venture partners | 2.50M | 37.74% | $19.98M |
| Lynx1 capital management lp | 9.26M | 1.97% | $5.25M |
| Vestal point capital, lp | 6.10M | 0.13% | $2.44M |
| Orbimed advisors | 6.06M | 0.06% | $2.42M |
| Tang capital management | 1.50M | 0.03% | $600.45K |
| Bridgeway capital management | 556.14K | 0.01% | $315.39K |
| Rbf capital | 142.81K | 0.00% | $57.17K |
| Renaissance | 1.38M | 0.00% | $783.43K |
| Fiduciary trust | 215.00K | 0.00% | $86.06K |
| Xtx topco | 60.89K | 0.00% | $24.37K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Lynx1 capital management lp | 9.26M | 1.97% | 830.00K |
| Tower research capital llc (trc) | 54.48K | 0.00% | 49.45K |
| State street | 156.77K | - | 32.90K |
| Geode capital management | 531.57K | - | 22.05K |
| Xtx topco | 60.89K | 0.00% | 15.49K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Versant venture management | - | - | -4.03M |
| Vanguard group | - | - | -2.04M |
| Orbimed advisors | 6.06M | 0.06% | -979.33K |
| Acuitas investments | - | - | -471.81K |
| Affinity asset advisors | - | - | -264.27K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Two sigma securities | 11.72K | 0.00% | 11.72K | $4.69K |
| Raymond james financial | 6.39K | - | 6.39K | $2.56K |
| Bnp paribas arbitrage, snc | 186.00 | - | 186.00 | $105.00 |
Sold Out
| Holder | Change |
|---|---|
| Qube research | -4.00 |
| Federation des caisses desjardins du quebec | -10.00 |
| Mid-american wealth advisory group | -32.00 |
| Farther finance advisors | -50.00 |
| Harbour investments | -60.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 39 | -4.88% | 35,055,187 | 3.65% | 55 | 1.87% | 16 | 6.67% | 11 | - |
| Mar 31, 2025 | 42 | -4.55% | 36,319,837 | -3.48% | 58 | 1.58% | 15 | -25.00% | 11 | 10.00% |
| Dec 31, 2024 | 13 | -70.45% | 6,312,660 | -83.67% | 10 | 0.26% | 5 | -72.22% | 4 | -42.86% |
| Sep 30, 2024 | 44 | - | 38,667,152 | 2.24% | 62 | 1.39% | 19 | 72.73% | 7 | -36.36% |
| Jun 30, 2024 | 44 | -12.00% | 37,821,661 | -0.07% | 67 | 1.42% | 11 | -45.00% | 11 | -15.38% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Worldwide Healthcare Ord | 2.03M | 3.28% | - |
| Vanguard US Total Market Shares ETF | 1.50M | 2.41% | - |
| Vanguard Total Stock Mkt Idx Inv | 73.23K | 2.35% | -1.60K |
| Vanguard Institutional Extnd Mkt Idx Tr | 25.59K | 0.82% | 924.00 |
| Bridgeway Ultra-Small Company | 416.04K | 0.67% | - |
| Galileo - Biotech Innovation Fund S USD | 412.28K | 0.65% | - |
| Fidelity Extended Market Index | 14.40K | 0.45% | - |
| iShares Micro-Cap ETF | 101.78K | 0.16% | - |
| Bridgeway Ultra-Small Company Market | 90.10K | 0.14% | -50.00K |
| Fidelity Total Market Index | 4.07K | 0.13% | 1.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 11, 2025 | Lynx1 Capital Management LP | - | Buy | $2.26K |
| Sep 15, 2025 | Lynx1 Capital Management LP | - | Buy | $83.18K |
| Sep 12, 2025 | Lynx1 Capital Management LP | - | Buy | $138.30K |
| Jul 23, 2025 | Lynx1 Capital Management LP | - | Buy | $283.03K |
| Jul 24, 2025 | Lynx1 Capital Management LP | - | Buy | $379.45K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | 6 | - |
| 2025 Q2 | - | 9 |
| 2025 Q1 | - | 7 |
| 2024 Q4 | 4 | 6 |
| 2024 Q3 | - | 4 |
PASG Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools